In Brief: Instromedix' LifeSigns
This article was originally published in The Gray Sheet
Executive Summary
Instromedix' LifeSigns: Home-based patient monitoring system clears FDA, the Hillsboro, Oregon-based firm reports. The system is indicated for stabilized patients who may have compensated congestive heart failure, a history of myocardial infarction, symptoms of coronary artery disease, cardiac arrhythmias, conditions requiring Sp02 and high blood pressure monitoring and post-op cardiac recovery. Components of the system, which collects and transmits patient data to a medical facility via a standard telephone line, include the Shuttle, a portable patient monitor; the Commander, a telecommunications port for direct communication between patient and physician during data transfer; and the Central Station, a computerized patient management program...